Scientists have succeeded in identifying mechanisms that protect people from an Epstein-Barr virus-induced autoimmune reaction and thus potentially from multiple sclerosis (MS). The study suggests possible targets for the development of a vaccine to protect against MS.

Scientists have succeeded in identifying mechanisms that protect people from an Epstein-Barr virus-induced autoimmune reaction and thus potentially from multiple sclerosis (MS). The study suggests possible targets for the development of a vaccine to protect against MS.